A Revolution in HIV/AIDS Treatment
By German Velasquez
On September 25, 2025, two voluntary licensing agreements were announced between Gilead, the patent holder, and generic drug manufacturers in India for the supply of generic lenacapavir at $40 (instead of the original $28,218) per patient per year. However, too many countries are excluded from the agreements.
The negotiations on the Pathogen Access and Benefit Sharing System under the WHO Pandemic Agreement: State of Play as of September 2025
By Viviana Munoz Tellez, German Velasquez
The World Health Organization (WHO) Member States adopted a Pandemic Agreement in May 2025 but deferred negotiations on the critical Pathogen Access and Benefit Sharing System (PABS). Despite the tight timeline, the Intergovernmental Working Group (IGWG) has made minimal progress as of September 2025, with no draft text produced and formal negotiations yet to begin. The PABS system is essential for pandemic equity, balancing rapid pathogen sharing with equitable access to vaccines and treatments. But with the current approach to the IGWG process, without formal negotiations underway, Member States risk failing to finalize the PABS Annex by the March 2026 deadline.
Negotiating Global Health Policies
Tensions and Dilemmas
Description:
This book presents reflections and research that highlight tensions in the negotiations on pandemic preparedness treaties and revisions to the International Health Regulations, underscoring the geopolitical divide between developed and developing countries. It advocates regional health initiatives as a response to the multilateral impasse and reflects on the erosion of foundational public health concepts such as “essential medicines”.
New pandemics are inevitable. How can we best prepare for them and, above all, how can we avoid the mistakes and injustices made during the COVID-19 pandemic?
How can equitable access to medicines and diagnostics be guaranteed when they are produced in a small number of countries? How can we explain the fact that current funding for cooperation in the field of health is in the hands of a small group of Northern countries and foundations from the North? How can the role of the World Health Organization be strengthened? WHO now plays only a minor role in coordinating public health policies. How is it that the concept of “essential medicines”, a major advance in public health policy, is being replaced by that of “medical countermeasures”, a term more in line with the private sectors?
Preparing for future pandemics forces us to ask ourselves: how can we safeguard the general interest, the defense of human rights and public health?
Negotiating Global Health Policies: Tensions and Dilemmas is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO), the World Trade Organization (WTO), and the World Intellectual Property Organization (WIPO) who participate in international negotiations on health and development. Academics and students of medicine, health sciences, law, sociology and political science, as well as intergovernmental organizations and non-governmental organizations who work on access to medicines and global health issues, also would find the book of interest.
Author: Germán Velásquez is Special Adviser, Policy and Health of the South Centre in Geneva, Switzerland. Previously, he was Director of the Secretariat on Public Health, Innovation and Intellectual Property at WHO. He represented WHO at the WTO TRIPS Council from 2001 to 2010. He is the author and co-author of numerous publications on health economics and medicines, health insurance schemes, globalization, international trade agreements, intellectual property and access to medicines.
He obtained a Master’s degree in Economics and a PhD in Health Economics from Sorbonne University, Paris. In 2010, he received a Honoris Causa PhD on Public Health from the University of Caldas, Colombia and in 2015 he received another Honoris Causa PhD from the Faculty of Medicine of the Complutense University of Madrid, Spain.
New Amendments to the International Health Regulations: Strengthening Access to Health Products in Emergencies and Pandemics
By Viviana Munoz Tellez
The International Health Regulations amendments entered into force on September 19, 2025 across most World Health Organization (WHO) Member States. These updates don’t give WHO any new powers but help countries work better together to advance fair and timely access to health products such as vaccines, treatments and diagnostics needed to respond to health emergencies. The real challenge now is implementation and building the necessary capabilities to make these improvements function.
South Centre IGWG2 Statement
19 September 2025
Critical statement from South Centre on IGWG Pandemic Agreement Annex PABS System. Key recommendations inside:
Working Document – Pathogen Access and Benefit Sharing System
3 September 2025
This document is a work in progress intended to assist in the understanding of the ongoing negotiations in the WHO | IGWG for the establishment of a Pathogen Access and Benefit Sharing System as an Annex of the Pandemic Agreement, as described in Article 12.
Community Based Surveillance for AMR Monitoring: Significance, Requirements and Feasibility in LMICS
By Afreenish Amir
Community based surveillance, in addition to clinical antimicrobial resistance (AMR) surveillance, plays an essential role in AMR and antimicrobial use trend monitoring. Various community-based AMR surveillance studies to monitor trends in AMR and use of antimicrobials have been conducted and shown its potential to facilitate evidence-based interventions and policy making for control of AMR. Many low and middle income countries (LMICs) lack the necessary systems and resources to establish effective surveillance systems. Specifically, the surveillance capacity at hospitals and other health facilities is limited, and the overall human resource capacity for community-level data collection, analysis, and multi-sectoral coordination is severely constrained. Prior to planning for community based AMR surveillance, a country should have established mechanisms to run the system efficiently, including strong governance and regulations, surveillance infrastructure, laboratory capacities, skilled human resources, data collection and management, funding and sustainability.
The World Health Organization and quadripartite partners have recommended advancing community based AMR surveillance in LMICs, and integrated AMR surveillance combining information from humans, animals and ecosystems, which seems a challenge in the current situation. Considering the significant gaps in systems, resources, and capacities, it is important to prioritize strengthening the country’s core capacities and addressing the underlying gaps in healthcare systems. Efforts should focus on enhancing the country’s core capacities, systems, and technical requirements while exploring the potential of advancing selective community based AMR surveillance interventions and systems in the future.
Statement by the South Centre to the Seventy-eighth World Health Assembly
Agenda Item 15: Antimicrobial Resistance
27 May 2025
The South Centre strongly encourages member States and the Director General to maintain antimicrobial resistance as a WHO priority, with adequate resources in headquarters and regional offices, and increased coherence as a cross cutting issue across various WHO programmes …
Statement by the South Centre to the Seventy-eighth World Health Assembly
Agenda Item 13.9: Global strategy for Women’s, Children’s and Adolescents’ Health
26 May 2025
We support the implementation of the Global Strategy 2016 – 2030, with increased and sustained financing, towards meeting the health needs and realizing the rights of all women, children and adolescents.
Key interventions include expanding immunization coverage, promoting breastfeeding, improving nutrition, advancing gender equality, and advancing sexual and reproductive health information and services for women and adolescents.
We strongly support the resolution regulating the digital marketing of breast-milk substitutes.
South-South Cooperation to Address Health Challenges in the Caribbean. The Role of Medical Cooperation
Side Event organized by the South Centre and the Republic of Cuba during the World Health Assembly 2025
Date and Time: 20th May 2025, 6:00 – 7:30pm
Venue: South Centre (IEV II Conference Centre, Ground Floor, room Rhin, Chemin de Balexert 7/9, 1219 Geneva)
Within the framework of the World Health Assembly 2025, this side event, organized by Cuba, will bring together distinguished Ministers of Health from the Caribbean and Latin America to exchange experiences on the current challenges facing their health systems and the solutions implemented through South-South cooperation.
The panel will focus on how to strengthen South-South collaboration in the health sector, with the aim of building more resilient, equitable, and sustainable health systems in the Caribbean region.
This session will explore how collaboration between Caribbean and Latin American countries has contributed to strengthening regional health systems. Successful initiatives in medical training, professional exchange, and technical assistance will be highlighted. Additionally, innovative medical cooperation strategies that have improved access to and quality of health services for the most vulnerable populations will be discussed, consolidating an exemplary model of solidarity and mutual support.
The event will be conducted in Spanish with simultaneous interpretation into English.
Webinar Report:
Advancing Antimicrobial Stewardship Policies: Lessons from the COVID-19 Pandemic and Priorities for Future Health Emergencies
By Dr Rasha Abdelsalam Elshenawy
Our recent South Centre webinar examined how the pandemic created a dual challenge for global health:
– MISUSE: 35-75% of hospitalized COVID-19 patients received antibiotics despite low bacterial co-infection rates.
– ACCESS BARRIERS: The pandemic disrupted supply chains and healthcare access, limiting antimicrobial availability in many regions.
This paradox—overuse alongside access challenges—must inform future pandemic preparedness.
Our experts call for:
– Integrating antimicrobial stewardship into emergency response
– AMS frameworks must be established BEFORE health emergencies
– Strengthening surveillance systems and diagnostic capacity
– Ensuring sustainable and equitable access to antimicrobials
Scaling Up the Health Response to Climate Change: Highlights from the World Health Organization Executive Board’s 156th Meeting on the Global Action Plan on Climate Change and Health
By Bianca Carvalho
The Executive Board of the World Health Organization (WHO), during its 156th meeting held from 3-11 February 2025, discussed a draft Global Action Plan on Climate Change and Health (2025 – 2028) (EB156/40). This policy brief explains the content of the draft Global Action Plan and summarises the feedback provided by Member States during the Executive Board meeting.
Member States at the 156th WHO Executive Board meeting made recommendations for the Global Action Plan, including to ensure that equity remains central, to foster collaboration across sectors, and to enhance support mechanisms—both technical and financial—for developing countries addressing the intersection of climate change and health challenges. Member States also called for more consultations before the draft Global Action Plan is considered for adoption at the 78th World Health Assembly in May 2025.
